AxoGen (AXGN) Q2 Earnings and Revenues Beat Estimates

AxoGen (AXGN) came out with quarterly earnings of $0.05 per share, beating the Zacks Consensus Estimate of a loss of$ 0.05 per share. This compares to loss of $0.03 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 200%. A quarter ago, it was expected that this regenerative medicine company would post a loss of$ 0.10 per share when it actually produced a loss of $0.06, delivering a surprise of 40%.Over the last four quarters, th ...